C83.79 ICD-10-CM Code: Burkitt lymphoma, extranodal and solid organ sites
C83.79 maps to CMS-HCC V28 20 (RAF 1.136). Documentation must support MEAT. MEAT criteria · RAF calculator · free HCC coding tools
HCC Buddy Code Card
Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.
FY 2026 Apr update / Neoplasms (C00-D49) / Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)
C83.79
Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidanceBurkitt lymphoma, extranodal and solid organ sites
Burkitt lymphoma that has spread to organs outside the lymph node system, such as the liver, spleen, bone marrow, or other solid organs.

Buddy Insight
Burkitt lymphoma involving extranodal and solid organ sites represents disease that has spread beyond the lymphatic system into organs such as the gastrointestinal tract, liver, kidneys, or central nervous system.
CMS-HCC V28
MappedHCC 20
RAF 1.136
CMS-HCC V24
MappedHCC 10
RAF 0.675
ACA/HHS
MappedHCC 10
Varies by metal level
ESRD/PACE
MappedHCC 10
RAF 0.111
RXHCC
MappedHCC 21
RAF 0.410
Code Book Path
Inclusion Terms
Official- Atypical Burkitt lymphoma
- Burkitt-like lymphoma
Excludes 2
OfficialICD-10-CM does not list Excludes 2 notes for C83.79 in this effective period.
Related Child Codes
Includes
OfficialICD-10-CM does not list Includes notes for C83.79 in this effective period.
Excludes 1
Official- mature B-cell leukemia Burkitt type (C91.A-)
Code First
OfficialICD-10-CM does not list Code First sequencing instructions for C83.79 in this effective period.
Use Additional
OfficialICD-10-CM does not list Use Additional Code instructions for C83.79 in this effective period.
Code Also
OfficialICD-10-CM does not list Code Also instructions for C83.79 in this effective period.
Buddy Documentation Tip
MEAT Support
Audit Caution
Common Mistakes
Current with CMS: FY2026 ICD-10-CM Apr 1 update (effective Apr 1 – Sep 30, 2026) · CMS-HCC V28, 100% phased in for payment year 2026. FY2027 code set already staged for October 1, 2026. How HCC Buddy stays current →
Is C83.79 an HCC code?
Yes. C83.79 (Burkitt lymphoma, extranodal and solid organ sites) maps to Lung and Other Severe Cancers under the CMS-HCC V28 risk adjustment model (and Lymphoma and Other Cancers under V24), with a community non-dual aged RAF of 1.136. It is billable for payment year 2026.
Coder answer: C83.79 is billable and maps to V28 HCC 20, Lung and Other Severe Cancers. Open it in the Code Book for the tabular path, RAF, and MEAT checklist.
- Code
- C83.79
- Description
- Burkitt lymphoma, extranodal and solid organ sites
- HCC (V28)
- HCC 20 — Lung and Other Severe Cancers
- RAF
- 1.136
- Billable
- Yes
- Payment year
- 2026
HCC Category Mapping
Each model's RAF is its CMS base weight for that model's standard population, so weights are not directly comparable across models: CMS-HCC V28 and V24 use Community, Non-Dual, Aged; ESRD uses the dialysis continuing-enrollee model; RxHCC is the Part D continuing-enrollee, non-low-income, aged weight (a larger scale than CMS-HCC). ACA/HHS has no single weight — it varies by metal level. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.
Work C83.79 in the Code Book — tabular path, V28 RAF, and MEAT checklist →
MEAT Criteria for C83.79
For C83.79 to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically, it has to be re-documented and supported each calendar year.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed C83.79 during that encounter, not just copy-forwarded from a problem list.
Coder workflow notes
Get the V28 RAF + MEAT cheat sheet
One printable page: confirm a code's V28 HCC status, its RAF weight, and the MEAT your note needs to make it stick. Free, no card.
Free PDF. No card. Unsubscribe anytime.
What This Code Means
C83.79 is the ICD-10-CM diagnosis code for burkitt lymphoma, extranodal and solid organ sites. Burkitt lymphoma that has spread to organs outside the lymph node system, such as the liver, spleen, bone marrow, or other solid organs. C83.79 sits in the ICD-10-CM chapter for neoplasms (c00-d49), within the section covering malignant neoplasms of lymphoid, hematopoietic and related tissue (c81-c96).
Under the CMS-HCC V28 risk adjustment model, C83.79 maps to Lung and Other Severe Cancers (HCC 20) with a community, non-dual, aged base RAF weight of 1.136. Under the older CMS-HCC V24 model, C83.79 maps to Lymphoma and Other Cancers (HCC 10) with a community, non-dual, aged base RAF weight of 0.675. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.
This code indicates extranodal involvement, meaning the cancer has spread beyond lymph nodes to solid organs or tissues. Because C83.79 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for C83.79 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •This code indicates extranodal involvement, meaning the cancer has spread beyond lymph nodes to solid organs or tissues
- •Document the specific organs involved in the medical record for complete clinical documentation
Clinical Significance
Burkitt lymphoma involving extranodal and solid organ sites represents disease that has spread beyond the lymphatic system into organs such as the gastrointestinal tract, liver, kidneys, or central nervous system. This pattern indicates advanced-stage disease requiring intensive multimodal treatment including central nervous system prophylaxis. Extranodal Burkitt lymphoma carries unique management challenges and high resource utilization.
Documentation Requirements
- ✓Pathology confirming Burkitt lymphoma histology
- ✓Specific documentation of which extranodal organs are involved (gastrointestinal tract, bone marrow, central nervous system, liver, etc.)
- ✓Imaging confirming extranodal disease spread
- ✓Staging documentation reflecting extranodal involvement
- ✓Current treatment status and response assessment
Commonly Confused Codes
- •C83.78: Burkitt lymphoma, lymph nodes of multiple sites: Use for multi-site nodal disease; C83.79 is specifically for disease in organs outside the lymph node system
- •C83.77: Burkitt lymphoma, spleen: The spleen code is separate from extranodal; if only the spleen is involved, use C83.77
- •C83.89: Other non-follicular lymphoma, extranodal: Use when the extranodal lymphoma is a non-Burkitt subtype

